A Phase 1b Study Of Axitinib In Combination With Crizotinib In Patients With Advanced Solid Tumors
Clinical trial NCT01999972 · COMPLETED
Trial details
- NCT number
- NCT01999972
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-26
- Primary completion
- 2017-02-22
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.